Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.4005
+0.0111 (2.85%)
At close: Oct 8, 2025, 4:00 PM EDT
0.3843
-0.0162 (-4.04%)
After-hours: Oct 8, 2025, 6:08 PM EDT
Adial Pharmaceuticals Stock Forecast
ADIL's stock price has decreased by -58.22% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Adial Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $4.75, which forecasts a 1,086.02% increase in the stock price over the next year. The lowest target is $1.50 and the highest is $8.00.
Price Target: $4.75 (+1,086.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Adial Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $1.5 | Hold → Strong Buy | Upgrades | $1.5 | +274.53% | Sep 30, 2025 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +1,897.50% | Nov 14, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +37,353.18% | Jul 11, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 17, 2022 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +74,806.37% | Oct 13, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.54
from -2.72
EPS Next Year
-0.92
from -0.54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.55 | -0.84 | |||
| Avg | -0.54 | -0.92 | |||
| Low | -0.52 | -0.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.